Major advance in cell reprogramming technology

Apr 23, 2009

In a paper publishing online April 23rd in Cell Stem Cell, a Cell Press journal, Dr. Sheng Ding and colleagues from the Scripps Research Institute in La Jolla, California, report an important step forward in the race to make reprogrammed stem cells that may be better suited for use in clinical settings.

Ding and his colleagues show that mouse cells can be reprogrammed to form with a combination of purified proteins and a chemical additive, thus avoiding the use of .

The discovery three years ago that adult cells could be reprogrammed to form induced pluripotent stem cells, or iPS cells, with similar properties to embryonic stem cells was a major scientific breakthrough. These cells hold enormous potential for drug development and even cell therapy processes, and this promise has garnered significant attention from scientists and the media worldwide. However, a major caveat to the eventual application of iPS cells is that until now all the methods used to generate them have required the introduction of genetic material to make the needed for reprogramming. Although some research groups have recently generated iPS cells that lack genetic modifications, even the most advanced methods used genes in the form of plasmids, and thus the risk of genetic mutations caused by the introduced sequences remained.

In their new paper, Ding and co-authors avoid this risk entirely by adding specially modified versions of reprogramming proteins directly to the growing fibroblasts. The proteins are broken down by the cells after they are added to the culture, so to sustain protein activity long enough to induce reprogramming the authors used repeated cycles of protein addition. Ding and colleagues named the reprogrammed cells that arise from this process "protein-induced pluripotent stem cells," or piPS cells.

The piPS cell protocol "represents a significant advance in generating iPS cells, and has several advantages over previous iPS cell methods" says Ding. Reprogramming without genetic material is a milestone that many in the iPS cell field have been seeking to achieve, and doing so will provide further fuel for the rapid progress of this highly exciting area of biomedical research.

Source: Cell Press (news : web)

Explore further: New computer simulations help scientists understand how—and why—viruses spread

add to favorites email to friend print save as pdf

Related Stories

Researchers piggyback to safer reprogrammed stem cells

Feb 27, 2009

Austin Smith and his research team at the Centre for Stem Cell Research in Cambridge have just published in the journal Development a new and safer way of generating pluripotent stem cells - the stem cells that can give r ...

New technique produces genetically identical stem cells

Jul 01, 2008

Adult cells of mice created from genetically reprogrammed cells—so-called induced pluripotent stem (IPS) stem cells—can be triggered via drug to enter an embryonic-stem-cell-like state, without the need for further genetic ...

Recommended for you

A feline fungus joins the new species list

23 hours ago

(Phys.org) —A new species of fungus that causes life-threatening infections in humans and cats has been discovered by a University of Sydney researcher.

New way to improve antibiotic production

Jun 17, 2013

An antibiotic has been found to stimulate its own production. The findings, to be published in PNAS, could make it easier to scale up antibiotic production for commercialisation.

User comments : 0

More news stories

Origins of 'The Hoff' crab revealed (w/ Video)

The history of a new type of crab, nicknamed 'The Hoff' because of its hairy chest, which lives around hydrothermal vents deep beneath the Southern Ocean and Indian Ocean, has been revealed for the first ...

Cape Wind gets $200M investment from Danish fund

The Cape Wind offshore wind project has secured a $200 million investment from a Danish pension fund in what the wind farm's president said Tuesday is a milestone for the long-delayed project.